cbdMD, Inc. (YCBD)

Revenue by Segment

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018
Pharmaceuticals	19.19M	19.48M	-	-	-
Pharmaceuticals Growth	-1.50%	-	-	-	-
Total	19.19M	19.48M	-	-	-
Total Growth	-1.50%	-	-	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018
United States	19.19M	19.48M	24.16M	35.40M	44.48M
United States Growth	-1.50%	-19.35%	-31.77%	-20.41%	6.20%
Total	19.19M	19.48M	24.16M	35.40M	44.48M
Total Growth	-1.50%	-19.35%	-31.77%	-20.41%	6.20%

Data Source: S&P Global Market Intelligence Last updated: Feb 17, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 23, 2026

Data Sources Report a data error